Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

Código QR

Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Koji Nakajima, Ayumi Korekawa, Daiki Rokunohe, Hajime Nakano, Daisuke Sawamura
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	anemia jaundice melanoma metastasis nivolumab Dermatology RL1-803 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/07689a31d97d491c824f04b261b45b9e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nivolumab-Induced Exocrine Pancreatic Insufficiency
por: Boudewijn Sweep, et al.
Publicado: (2021)

A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA)
por: Flavia Dei Zotti, et al.
Publicado: (2021)

A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
por: Keisuke Minami, et al.
Publicado: (2021)

Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
por: Morten Fink, et al.
Publicado: (2021)

Autoimmune hemolytic anemia in children: Clinical presentation and treatment outcome
por: Satyam Arora, et al.
Publicado: (2021)

Concomitant autoimmune hemolytic anemia and pulmonary embolism associated with mild COVID‐19: A case report
por: Abdulrahman F. Al‐Mashdali, et al.
Publicado: (2021)

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
por: Huo Geng-wei, et al.
Publicado: (2021)

Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review
por: Ammar Haikal, et al.
Publicado: (2018)

Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma
por: Pramod Savarapu, et al.
Publicado: (2021)

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab
por: Koji Iinuma, et al.
Publicado: (2021)

Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient
por: Minal Wasnik, et al.
Publicado: (2021)

Reporte de dos casos clínicos de melanoma con metástasis cardíacas: ("Dos caras de una misma moneda")
por: Cabrera,Ignacio, et al.
Publicado: (2016)

Late diagnosis of nodular melanoma of the foot in a 74-year-old Brazilian man
por: Santos,Vitorino M, et al.
Publicado: (2011)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021)

Melanoma metastásico con tumor primario oculto
por: Bórquez M,Pablo, et al.
Publicado: (2012)

Canine autoimmune hemolytic anemia: management challenges
por: Swann JW, et al.
Publicado: (2016)

Hemolytic anemia caused by hereditary pyruvate kinase deficiency in a West Highland White Terrier dog
por: Hlavac,NRC, et al.
Publicado: (2012)

Cefazolin-induced hemolytic anemia: a case report and systematic review of literature
por: Elizabeth Mause, et al.
Publicado: (2021)

Use of nivolumab for colon cancer with Lynch syndrome
por: G. A. Khakimov, et al.
Publicado: (2020)

Adrenalectomía bilateral laparoscópica por metástasis asincrónica de melanoma: comunicación de un caso con sobrevida prolongada
por: Molina E,Roberto, et al.
Publicado: (2013)

Anemia aplástica idiopática
por: GALASSO VICARI,WALTER, et al.
Publicado: (1955)

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
por: Paula Colón-Bolea, et al.
Publicado: (2021)

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Hiroto Yoneda, et al.
Publicado: (2021)

First report of expansion of CD4+/CD28 null T-helper lymphocytes in adult patients with idiopathic autoimmune hemolytic anemia
por: Soha R. Youssef, et al.
Publicado: (2021)

IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
por: Taylor A. Harper, et al.
Publicado: (2021)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Mizue Terai, et al.
Publicado: (2021)

New targeted treatments for non-small-cell lung cancer – role of nivolumab
por: Zago G, et al.
Publicado: (2016)

Anemia aplástica
por: URRUTIA,FIDEL
Publicado: (1948)

Anemia aplástica
por: URRUTIA,FIDEL
Publicado: (1948)

Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
por: Marc-Oliver Grimm, et al.
Publicado: (2021)

Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
por: Y ZahedPasha, et al.
Publicado: (2006)

Immune-Mediated Hemolytic Anemia Associated with Candidatus Mycoplasma Haematoparvum in a Splenectomized Dog in Italy
por: Rosanna Zobba, et al.
Publicado: (2020)

Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
por: Francesco Autore, et al.
Publicado: (2021)

Anemias en el lactante
por: ARIZTIA,ANIBAL, et al.
Publicado: (1942)

Anemia megaloblástica de la infancia
por: CASSORLA,EDUARDO, et al.
Publicado: (1960)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Bruno Fattizzo, et al.
Publicado: (2021)

LITHOLYTIC THERAPY AT THE TREATMENT OF CHOLELITHIASIS (REVIEW OF LITERATURE)
por: E. V. Razmakhnin, et al.
Publicado: (2014)

Evolución prolongada en síndrome de Crigler-Najjar tipo I
por: Besa,Santiago, et al.
Publicado: (2014)